How can we help?

Home

Beta 2 Glycoprotein 1 IgG Serum

Also referred as

Beta-2 Glycoprotein 1 IgG

Anti-Beta-2 Glycoprotein 1

β2-Glycoprotein 1 Antibodies

Beta 2GP1 Ab

For men & women

Earliest reports in

192 hours

Contains

1 test

Know more about this test

The Beta 2 Glycoprotein 1 IgG Serum is a blood test that detects immunoglobulin G (IgG) antibodies against Beta 2 Glycoprotein 1 (β2GPI), a protein that plays a key role in the blood clotting process. These antibodies are associated with autoimmune disorders such as antiphospholipid syndrome (APS), and their presence can increase the risk of clotting complications, including stroke, heart attack, and recurrent miscarriages.

Samples required

Blood

Find out

Why is this test booked?

Preparations

No special preparation is required.

Sample Collection

Who will collect your samples?

Understanding Beta 2 Glycoprotein 1 IgG Serum

Beta 2 Glycoprotein 1 (β2GPI) is a protein involved in regulating the blood clotting cascade. When the immune system mistakenly targets β2GPI, it produces anti-β2GPI antibodies. The Beta 2 Glycoprotein 1 IgG Serum test specifically identifies IgG antibodies against β2GPI in the blood, which is an important marker in diagnosing autoimmune conditions like antiphospholipid syndrome (APS).

APS is an autoimmune disorder in which the body produces antibodies that attack phospholipids or proteins in the cell membranes, leading to an increased risk of abnormal blood clot formation. These clots can cause severe complications such as deep vein thrombosis (DVT), pulmonary embolism (PE), stroke, myocardial infarction (heart attack), and recurrent pregnancy loss.

The Beta 2 Glycoprotein 1 IgG Serum test is crucial for diagnosing APS, particularly when blood clotting events or pregnancy complications are unexplained. It also helps to assess the level of risk for developing blood clots and guide the appropriate management of anticoagulation therapy. This test is often used to evaluate the presence of persistent antiphospholipid antibodies in individuals with APS or systemic lupus erythematosus (SLE), as these conditions share similar autoantibodies and risk factors. For individuals with a history of thrombosis, miscarriage, or unexplained vascular events, this test can provide vital information to help prevent further complications. It can also be useful in monitoring the effectiveness of treatments and the potential for clotting events. The presence of IgG antibodies typically indicates a chronic or long-standing autoimmune response, and their detection may suggest a higher long-term risk of thrombotic events.

This test is particularly useful in conjunction with clinical evaluation and other blood tests, as the diagnosis of APS requires evidence of both clinical symptoms (such as blood clots or miscarriage) and laboratory findings (including the presence of anti-β2GPI antibodies). In some cases, elevated IgG levels may be a marker of disease activity, helping doctors tailor treatment plans and adjust medications accordingly.

No special preparation is needed before theBeta 2 Glycoprotein 1 IgG Serum test. However, inform the doctor about any medications or supplements being taken, as certain medications may affect the test results.

Lab test results may vary across laboratories. Interpretation of the test results requires professional expertise. Therefore, do not self-medicate. Always consult a doctor to understand the test results correctly.

What does Beta 2 Glycoprotein 1 IgG Serum measure?

The Beta 2 Glycoprotein 1 IgG Serum test detects the presence of immunoglobulin G (IgG) antibodies against Beta 2 Glycoprotein 1, a protein that plays a crucial role in regulating blood clotting. IgG indicates a chronic or ongoing immune response against β2GPI, which is often associated with an increased risk of blood clotting disorders such as those seen in APS. Elevated levels of these antibodies suggest a higher risk for thrombotic events, such as deep vein thrombosis (DVT), stroke, or miscarriage, particularly when coupled with other clinical factors. By detecting IgG antibodies, this test aids in diagnosing APS and determining the need for medical interventions to manage clotting risk, including anticoagulant therapy or closer monitoring in pregnancy.

Frequently booked together

FAQs related to Beta 2 Glycoprotein 1 IgG Serum

What is the Beta 2 Glycoprotein 1 IgG Serum test?

The Beta 2 Glycoprotein 1 IgG Serum test detects the presence of immunoglobulin G (IgG) antibodies against Beta 2 Glycoprotein 1 (β2GPI), a protein involved in regulating blood clotting. These antibodies are commonly associated with autoimmune conditions like antiphospholipid syndrome (APS), which increases the risk of abnormal blood clots.

Why is this test done?

This test is used to diagnose or assess the risk of conditions such as antiphospholipid syndrome (APS), systemic lupus erythematosus (SLE), and other autoimmune disorders that can lead to abnormal clotting. It is especially helpful for investigating unexplained blood clots, recurrent miscarriages, stroke, or myocardial infarction (heart attack). The test helps determine the need for anticoagulation therapy or other treatments.

Do I need to prepare for the Beta 2 Glycoprotein 1 IgG Serum test?

No specific preparation is required for this test. However, it’s important to inform your doctor about any medications or supplements you're taking, as certain drugs may influence test results.

What do the results mean?

A positive result means that IgG antibodies against Beta 2 Glycoprotein 1 have been detected in your blood. This may suggest the presence of antiphospholipid syndrome (APS) or another autoimmune condition. It indicates an increased risk of clotting, which may require further investigation or treatment. A negative result suggests that IgG antibodies were not detected. However, a negative result does not rule out APS or other clotting disorders entirely. Additional tests may be required, especially if symptoms persist.

Can the test be used to monitor the progression of the disease?

Yes, the Beta 2 Glycoprotein 1 IgG Serum test can help monitor disease activity in individuals with APS or other autoimmune disorders. Elevated levels of IgG antibodies may indicate an active autoimmune response, which can increase the risk of blood clots and other complications. The test can help doctors track the effectiveness of treatment and adjust care plans accordingly.

Is the Beta 2 Glycoprotein 1 IgG Serum test the same as the Beta 2 Glycoprotein 1 IgM test?

No, the Beta 2 Glycoprotein 1 IgG Serum test specifically measures IgG antibodies, while the Beta 2 Glycoprotein 1 IgM test measures IgM antibodies. Both tests can detect antibodies against β2GPI, but IgM antibodies typically indicate a more recent or active immune response, while IgG antibodies are often associated with a longer-standing immune response or chronic disease.

Can the test be used for pregnant women?

Yes, this test can be used for pregnant women, especially if they have experienced recurrent miscarriages, clotting issues, or other complications. Elevated anti-β2GPI antibodies during pregnancy can increase the risk of miscarriage and other pregnancy-related issues, so testing may be recommended to assess risk and guide management.

Why is Beta 2 Glycoprotein 1 important in blood clotting?

β2GPI is involved in the regulation of the coagulation cascade (reactions that occur in response to bleeding to form a blood clot), which is the process by which the body forms blood clots to prevent excessive bleeding. It works by interacting with phospholipids on the surface of cells, particularly in the context of the blood vessel walls. When the body produces antibodies against β2GPI, it can disrupt this process, leading to an increased risk of abnormal clotting, which can cause conditions like deep vein thrombosis (DVT), stroke, and miscarriage.

How does Beta 2 Glycoprotein 1 relate to antiphospholipid syndrome (APS)?

In APS, the immune system mistakenly produces antibodies against β2GPI (as well as other phospholipids), which increases the risk of forming abnormal blood clots. These antibodies can interfere with the normal function of β2GPI and trigger clotting events. The presence of anti-β2GPI antibodies is a key marker for diagnosing APS, a condition associated with thrombosis, stroke, heart attack, and recurrent pregnancy loss.

Are there different types of Beta 2 Glycoprotein 1 antibodies?

Yes, there are different classes of antibodies against β2GPI, including IgM, IgG, and IgA. The IgG antibodies are typically associated with a longer-term or chronic immune response and are commonly measured in the Beta 2 Glycoprotein 1 IgG Serum test. IgM antibodies often indicate a more recent or active immune response. Both types of antibodies can contribute to the risk of blood clot formation, but IgG antibodies are often used for diagnosing and assessing APS.

How does Tata 1mg ensure accurate lab test results?

Tata 1mg ensures accurate lab test results through certified laboratories that use advanced technology and adhere to stringent quality control measures. This commitment to high standards guarantees reliable results.

Content created by

Dr. Swati Gupta (Anand)

MBBS, MD Lab Medicine

Want to know moreRead our editorial policy

Last Updated

16th Nov 2025